Edip Gonullu1, Sevda Ozkardesler2, Tuncay Kume3, Leyla Seden Duru2, Mert Akan2, Mehmet Ensari Guneli4, Bekir Ugur Ergur5, Reci Meseri6, Oytun Dora2. 1. Department of Anesthesiology, Van Training and Research Hospital, Van, Turkey. Electronic address: edipgonullu@gmail.com. 2. Department of Anesthesiology, School of Medicine, Dokuz Eylul University, Izmir, Turkey. 3. Department of Biochemistry, School of Medicine, Dokuz Eylul University, Izmir, Turkey. 4. Department of Laboratory Animal, School of Medicine, Dokuz Eylul University, Izmir, Turkey. 5. Department of Histology and Embryology, School of Medicine, Dokuz Eylul University, Izmir, Turkey. 6. Department of Nutrition and Dietetics, College of Health Sciences, Ege University, Izmir, Turkey.
Abstract
BACKGROUND AND OBJECTIVES: We investigated the effect of dexmedetomidine on ischemic renal failure in rats. METHODS: In the present study, 26 male adult Wistar albino rats weighting 230-300 g were randomly separated into four groups: sham-operated (n=5), ischemia reperfusion (IR) (IR group, n=7), IR/reperfusion treatment with dexmedetomidine (Dex. R group, n=7) and IR/pre-ischemic treatment with dexmedetomidine (Dex. I group, n=7). In the first group, sham operation was achieved and renal clamps were not applied. For the IR group, renal ischemia was induced by occlusion of the bilateral renal arteries and veins for 60 min followed by reperfusion for 24h. For the Dex. R and Dex. I groups, the same surgical procedure as in the IR group was performed, and dexmedetomidine (100 mcg/kg intraperitoneal) was administrated at the 5th min after reperfusion and before ischemia. At the end of reperfusion, blood samples were drawn, the rats were sacrificed, and the left kidney was processed for histopathology. RESULTS: The blood urea nitrogen (BUN) levels in groups Dex. R and Dex. I were significantly lower than in the IR group (p=0.015, p=0.043), although urine flow was significantly higher in group Dex. R (p=0.003). The renal histopathological score in the IR group was significantly higher than in the other groups. There was no significant difference between the Dex. R and Dex. I groups. CONCLUSIONS: The results were shown that administration of dexmedetomidine reduced the renal IR injury histomorphologically. Administration of dexmedetomidine in the reperfusion period was considered as more effective due to increase in urinary output and decrease in BUN levels.
BACKGROUND AND OBJECTIVES: We investigated the effect of dexmedetomidine on ischemic renal failure in rats. METHODS: In the present study, 26 male adult Wistar albino rats weighting 230-300 g were randomly separated into four groups: sham-operated (n=5), ischemia reperfusion (IR) (IR group, n=7), IR/reperfusion treatment with dexmedetomidine (Dex. R group, n=7) and IR/pre-ischemic treatment with dexmedetomidine (Dex. I group, n=7). In the first group, sham operation was achieved and renal clamps were not applied. For the IR group, renal ischemia was induced by occlusion of the bilateral renal arteries and veins for 60 min followed by reperfusion for 24h. For the Dex. R and Dex. I groups, the same surgical procedure as in the IR group was performed, and dexmedetomidine (100 mcg/kg intraperitoneal) was administrated at the 5th min after reperfusion and before ischemia. At the end of reperfusion, blood samples were drawn, the rats were sacrificed, and the left kidney was processed for histopathology. RESULTS: The blood ureanitrogen (BUN) levels in groups Dex. R and Dex. I were significantly lower than in the IR group (p=0.015, p=0.043), although urine flow was significantly higher in group Dex. R (p=0.003). The renal histopathological score in the IR group was significantly higher than in the other groups. There was no significant difference between the Dex. R and Dex. I groups. CONCLUSIONS: The results were shown that administration of dexmedetomidine reduced the renal IR injury histomorphologically. Administration of dexmedetomidine in the reperfusion period was considered as more effective due to increase in urinary output and decrease in BUN levels.
Authors: E Erkılıç; E Kesimci; F Alaybeyoğlu; I Kılınç; R Tural; A Yazgan; T Gümüş; A Sepici Dinçel; E G Dumlu; O Kanbak Journal: Drug Des Devel Ther Date: 2017-03-08 Impact factor: 4.162
Authors: Meral Erdal Erbatur; Şaban Cem Sezen; Aslıhan Cavunt Bayraktar; Mustafa Arslan; Mustafa Kavutçu; Muhammed Enes Aydın Journal: Libyan J Med Date: 2017-12 Impact factor: 1.657
Authors: Kathrin S König; Nicole Verhaar; Klaus Hopster; Christiane Pfarrer; Stephan Neudeck; Karl Rohn; Sabine B R Kästner Journal: PLoS One Date: 2020-04-29 Impact factor: 3.240
Authors: Özge Kuzgun; Sevda Özkardeşler; Şule Özbilgin; Mert Akan; Bekir Uğur Ergür; Gonca Kamacı; Mehmet Ensari Güneli; Nazire Ateş; Ali Rıza Şişman; Reci Meseri Dalak Journal: Turk J Anaesthesiol Reanim Date: 2018-09-06